1-5 of 5
Jose Francisco Tomas, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects Of Bendamustine Plus Rituximab On The Distribution Of Normal Peripheral Blood Leucocyte Populations In Advanced-Stage Chronic Lymphocytic Leukemia (CLL)

Georgiana Grigore, Martin Perez-Andres, PhD, Susana Barrena, Rosa Ana Rivas, Marcos González, MD, Pilar Rabasa, MD, Angeles Medina, Jose Francisco Tomas, MD, PhD, Fernando Solano, Javier De la Serna, MD, PhD, Jose García Marco, Mª José Allegue, Javier Loscertales, Inmaculada Pérez, Teresa Olave, MD, Julia Almeida, Alberto Orfao
Journal: Blood
Blood (2013) 122 (21): 5289.
https://doi.org/10.1182/blood.V122.21.5289.5289
Published: 2013
Journal Articles

A Phase 1/2 Study Of The Safety and Activity Of Escalating Doses Of Lenalidomide Plus Rituximab For Patients With Refractory Or Relapsed Chronic Lymphocytic Leukemia (LLC-Lenar-08)

Jose Francisco Tomas, MD, PhD, Marcos González, MD, Pilar Giraldo, MD PhD, Mª José Terol, Jose Antonio Pérez Simón, MD, PhD, Raquel de Oña, MD
Journal: Blood
Blood (2013) 122 (21): 5304.
https://doi.org/10.1182/blood.V122.21.5304.5304
Published: 2013
Journal Articles

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Armando Lopez-Guillermo, MD, PhD, Miguel A. Canales, MD, PhD, Ivan Dlouhy, Javier Briones, MD, Dolores Caballero, MD, PhD, Juan Manuel Sancho, Sr., MD, Santiago Mercadal Vilchez, MD, Jose María Moraleda, MD, María José Terol, MD, PhD, Antonio Salar, MD, Luis Palomera, MD, Santiago Gardella, MD, Isidro Jarque, MD, Secundino Ferrer, Joan Bargay, MD, Andres Lopez, Carlos Panizo, Anna Muntanola, MD, Carlos Montalban, Eulogio Conde, MD, PhD, Miguel Hernandez, MD, Alfons Soler, Julian Marin, MD, Jose García Marco, Guillermo Deben, José Francisco Tomas, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 369.
https://doi.org/10.1182/blood.V122.21.369.369
Published: 2013
Journal Articles

5-Azacytidine Versus Intensive Chemotherapy or BSC in Elderly (>60 years) Acute Myeloid Leukemia Patients. A Retrospective Analysis

Josefina Serrano, Adolfo de la Fuente, MD, Juan Bergua, José Falantes, Martín-Chacón Eusebio, López Juan Antonio, Martinez-Losada MC, Casaño J, Antonio Romero, Prieto Elena, Mendez G, Tabares S, Jose Francisco Tomas, MD, PhD, Sánchez-Garcia Joaquin, Torres Antonio
Journal: Blood
Blood (2011) 118 (21): 2612.
https://doi.org/10.1182/blood.V118.21.2612.2612
Published: 2011
Journal Articles

NK Cytotoxicity Is Decreased During the Early Posttransplant Period Following Pediatric Allogeneic Transplantation From Unrelated Donors Using CD3/CD19-Depleted Graft.

Antonio Pérez-Martínez, MD, PhD, Manuel Ramírez, MD, PhD, María Ruiz-Salmerón, Marta Gonzalez-Vicent, MD, PhD, S. Grande, Alvaro Lassaletta, MD, Juliáan Sevilla, MD, PhD, Jose Francisco Tomas, MD, PhD, Luis Madero, MD, PhD, Prof, Miguel Angel Diaz, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2434.
https://doi.org/10.1182/blood.V114.22.2434.2434
Published: 2009